National
Santorum denounced as ‘bigot’ at N.H. rally
Anti-gay candidate compares his views on marriage to Obama’s
Occupy New Hampshire protesters outside a Santorum campaign event (Blade photo by Michael Key)
MANCHESTER, N.H. — Rick Santorum faced a noisy reception from protesters over his anti-gay views at a Monday campaign stop in New Hampshire.
The former U.S. senator from Pennsylvania was jeered Monday night just before a campaign rally at Jillian’s Billiards Club in Manchester, N.H., where he was about to begin his final campaign event in New Hampshire before the primary vote Tuesday.
As Santorum made his way from his campaign van to the club entrance, a group of about a dozen demonstrators associated with the Occupy movement began chanting “Bigot! Bigot! Bigot!”
Brett Chamberlin, a straight 20-year-old college student, led others in a chant, assailing Santorum for his opposition to gay rights and marriage equality. Chamberlin shouted, “He says gay marriage … is a slippery slope … but we say that regulation … is a slippery slope, too!”
The protesters held signs expressing discontent with the current state of campaign finance laws. The bottom of the sign showed a Democratic donkey with three dollar signs and text reading, “MONEY OUT OF POLITICS #OCCUPY.”
Chamberlin, who is from Durham, N.H., concluded his chant by crying, “Rick Santorum! We don’t like bigots in New Hampshire!”
The protesters continued their chant of “Bigot! Bigot! Bigot!” after Santorum entered the building and pounded the signs on the ground.
Speaking to reporters, Chamberlin, who has participated in both Occupy Wall Street and Occupy New Hampshire protests, said problems with the election system prompted him to demonstrate.
“I’m here tonight because we believe that our system really is run by who can raise and spend the most money, which means that they pander to corporate contributions and anonymous PACs instead of responding to the constituents that they allege to represent,” Chamberlin said.
Chamberlin continued that voters “shouldn’t have to settle for the lesser of two evils” when selecting presidential candidates and “the bane of democracy is settling for the person whom you find the least deplorable.”
Brett Chamberlin (Blade photo by Michael Key)
Asked by the Washington Blade whether Santorum’s opposition to same-sex marriage was also a source of discontent, Chamberlin replied, “I think that I was picking on that because it’s simply the issue about which Rick Santorum is the most deplorable.”
Chamberlin said Santorum “uses that slippery slope argument” in arguments against same-sex marriage by suggesting it will lead to the legalization of bestiality and polygamy. Last week, Santorum said during a town hall if marriage was an inalienable right, one “could imagine all the different types of marriages that would happen.”
But Chamberlin identified several reasons why the senator was mistaken in predicting marriage equality would lead to adverse consequences.
“First of all, that slippery slope argument doesn’t hold,” Chamberlin said. “We’ve legalize gay marriage here in New Hampshire and nothing really happened. Everything is the exact same, except more people have the civil right of marriage. No. 2, that slippery slope argument was used by people who were against interracial marriage. There’s a long history of it being used by people that want to fight against progressive change.”
Chamberlin, a student of politics and journalism at New York University, said the slippery slope argument cuts both ways.
“When he says that you can use the government to justify the overwhelming morality of America — which is not true because an overwhelming majority of people do support gay marriage — well then where does the government interruption stop?” Chamberlin said. “Can they come into your house or tell you you can’t cut your sideburns or wear mixed-fabric clothing, which are also commandants that appear side-by-side with the anti-gay comments in Leviticus. So, it’s not founded in logic; it’s not founded in a knowledge of history or a knowledge of American civics.”
Asked how well he thinks Santorum will fare in the New Hampshire primary in the wake of his anti-gay comments, Chamberlin declined to handicap the candidate’s chances, but speculated the senator may do better in later contests.
“I learned after years of following politics not to make predictions,” Chamberlin said. “I think that as long he does better than expected, that’s a win for him. … He’ll certainly do well in South Carolina, though. It’s a far more conservative state and he can really push anti-gay [views] that he’s had to keep a little bit suppressed here in New Hampshire, where we’ve legalized gay marriage.”
Santorum has a notoriously anti-LGBT record, which he’s made known over the course of his candidacy for president by expressing opposition to same-sex marriage and, most recently, saying a child would be better off having parents in prison as opposed to parents of the same gender.
The hostile reception he received before his evening rally comes on the heels of a response regarding his opposition to same-sex marriage during a morning event at Derry-Salem Elks Lodge in Salem, N.H.
Asked whether his opposition to gay rights makes him an electable candidate, Santorum invoked an unlikely person whom he says shares his views as a reason why he could be a viable contender.
“Everyone on the stage yesterday and the day before has pretty much has the same exact position I have on those issues,” Santorum said. “President Obama says he has the same position I have on gay marriage.”
Republican presidential candidate Rick Santorum eludes protesters (Blade photo by Michael Key)
Santorum has been enduring questions for days on his opposition to marriage equality in town halls and has been criticized in the libertarian-leaning state for expressing those views. He enjoyed third place status in New Hampshire polls coming off his virtual tie with former Massachusetts Gov. Mitt Romney in the Iowa caucuses, but despite his strong showing there, hasn’t seen much traction in the state.
Santorum suggested that criticism over his position on marriage is unfair because he’s the only candidate that’s facing heat over the issue.
“The only difference is between myself and any of them is that when somebody asks me a question I answer it,” Santorum said.
It’s true that Obama doesn’t support same-sex marriage — much to the consternation of many LGBT advocates. But Obama and Santorum diverge tremendously on LGBT rights and government-recognition of same-sex couples.
Obama opposes a Federal Marriage Amendment and voted against it as a U.S. senator, while Santorum has pledged to back it as president and credits himself with being an architect of the measure while in the Senate. Obama has declared the Defense of Marriage Act unconstitutional and refused to defend it in court, but Santorum has criticized the president and has pledged to defend the anti-gay law. Santorum has compared relationships of people of the same sex to bestiality.
Clo Ewing, an Obama campaign spokesperson, articulated the differences between Obama and Santorum on LGBT issues in a statement to the Blade.
“President Obama has long believed that gay and lesbian couples deserve the same legal protections as straight couples,” Ewing said. “That’s why he has called for repeal of the so-called ‘Defense of Marriage Act’ and has taken steps to weaken this discriminatory law until the time it can be repealed legislatively.”
Ewing also noted that Santorum — as well as Romney — has signed a pledge from an anti-gay organization promising to oppose same-sex marriage if elected president.
“Meanwhile, both Mitt Romney and Rick Santorum signed the National Organization for Marriage’s pledge, which defends DOMA and pushes for a federal marriage amendment,” Ewing said.
Michael Cole-Schwartz, a Human Rights Campaign spokesperson, also rebuked Santorum for suggesting his positions on LGBT issues are anything like Obama’s.
“Rick Santorum has made a career out of opposing LGBT equality so it’s laughable that he would even attempt a comparison to President Obama’s record of progress,” Cole-Schwartz said. “Rick Santorum wants to do anything he can to stop marriage equality — including supporting DOMA, promising to appoint anti-gay judges and even advocating for a constitutional amendment to ban rights for gay couples, all diametrically opposed to President Obama’s positions.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
